Replimune

Forecast & Rating8 analysts currently cover Replimune, with about 25.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $10.67, about 23.6% upside from the current price of $8.63. Price targets range from $2.00 to $17.00 — a wide spread, showing clear disagreement over just how much Replimune can rise. Historically, about 21.5% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Replimune's outlook. Data as of Jul 22, 2026; for reference only and not investment advice.